The Technical AnalystExchange: MEX Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Genomma Lab Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.62% MXN16.98
America/New_York / 2 mai 2024 @ 15:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 16 377 mill |
| EPS: | 1.510 |
| P/E: | 11.25 |
| Earnings Date: | Apr 24, 2024 |
| SharesOutstanding: | 964.51 mill |
| Avg Daily Volume: | 3.52 mill |
| RATING 2024-05-02 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.81x |
| Company: PE 11.25 | sector: PE 13.83 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.81x |
| Company: PE 11.25 | industry: PE 13.83 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
MXN28.93 (70.39%) MXN11.95 |
| Date: 2024-05-03 |
| Expected Trading Range (DAY) |
|---|
|
MXN 16.51 - 17.45 ( +/- 2.79%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | MXN16.98 (1.62% ) |
| Volume | 2.84 mill |
| Avg. Vol. | 3.52 mill |
| % of Avg. Vol | 80.64 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For LABB.MX
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
LABB.MX
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.